Cargando…

Minimal residual disease in pediatric ALL

Detalles Bibliográficos
Autores principales:	Pui, Ching-Hon, Campana, Dario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667954/ https://www.ncbi.nlm.nih.gov/pubmed/29108220 http://dx.doi.org/10.18632/oncotarget.20856

Ejemplares similares

On the way to specifically targeting minimal residual disease?
por: Gebauer, Gerhard
Publicado: (2008)

Minimal residual disease in gastroesophageal adenocarcinoma: the search for the invisible
por: Tarazona, N., et al.
Publicado: (2022)

Clinical impact of minimal residual disease in blood and bone marrow of children with acute myeloid leukemia
por: Karol, Seth E., et al.
Publicado: (2023)

Is there a role for retinoids to treat minimal residual disease in neuroblastoma?
por: Matthay, K K, et al.
Publicado: (2000)

Cancer Special Issue: Early detection and minimal residual disease
por: Odeny, Beryne
Publicado: (2021)

Clinical Impact of Minimal Residual Disease in Children with Different Subtypes of Acute Lymphoblastic Leukemia Treated with Response-Adapted Therapy
por: Pui, Ching-Hon, et al.
Publicado: (2016)

Minimal residual disease detection by next-generation sequencing of different immunoglobulin gene rearrangements in pediatric B-ALL
por: Chen, Haipin, et al.
Publicado: (2023)

Targeting melanoma residual disease by USP7
por: Vishnoi, Monika, et al.
Publicado: (2018)

Minimal access surgery in Pediatric Surgery
por: Parelkar, Sandesh Vinod
Publicado: (2014)

Association of germline genetic variants in RFC, IL15 and VDR genes with minimal residual disease in pediatric B-cell precursor ALL
por: Dawidowska, Małgorzata, et al.
Publicado: (2016)

Advances in the Diagnosis and Treatment of Pediatric Acute Lymphoblastic Leukemia
por: Inaba, Hiroto, et al.
Publicado: (2021)

Documentation in neonatal and pediatric minimal access surgery
por: Saxena, Amulya K.
Publicado: (2022)

COVID-19 pneumonia-residual changes on CT scan are they all fibrosis
por: Kohli, Anirudh
Publicado: (2020)

The Transition from Open to Minimal Access Pediatric Surgery
por: Shah, Rasiklal Shamji
Publicado: (2022)

Implementation of the standard strategy for identification of Ig/TCR targets for minimal residual disease diagnostics in B-cell precursor ALL pediatric patients: Polish experience
por: Dawidowska, Małgorzata, et al.
Publicado: (2008)

Personalized therapy in pediatric high-risk B-cell acute lymphoblastic leukemia
por: Karol, Seth E., et al.
Publicado: (2020)

Balance deficits in long-term pediatric ALL survivors
por: Varedi, Mitra, et al.
Publicado: (2018)

The minimal access technique for cavoatrial renal cancer thrombectomy – should it be used in all cases?
por: Antoniewicz, Artur A., et al.
Publicado: (2015)

Minimal Residual Disease, Metastasis and Immunity
por: Badia-Ramentol, Jordi, et al.
Publicado: (2021)

Methods to detect minimal residual disease
por: Haferlach, Torsten
Publicado: (2018)

Transcriptome Analysis of Minimal Residual Disease in Subtypes of Pediatric B Cell Acute Lymphoblastic Leukemia
por: Sitthi-amorn, Jitsuda, et al.
Publicado: (2015)

Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia
por: O’Connor, David, et al.
Publicado: (2018)

CD19 CAR-T cell treatment conferred sustained remission in B-ALL patients with minimal residual disease
por: Lu, Wenyi, et al.
Publicado: (2021)

A decade of minimal access pediatric surgery in India
por: Shah, Anirudh
Publicado: (2008)

Molecular minimal residual disease in resected non-small cell lung cancer (NSCLC): results of specifically designed interventional clinical trials eagerly awaited
por: Denis, Marc G., et al.
Publicado: (2023)

The Challenge and Opportunity of Pediatric Antimicrobial Stewardship in Low Resource Settings
por: Iroh Tam, Pui-Ying
Publicado: (2019)

Assessment of Minimal Residual Disease in Ewing Sarcoma
por: Wagner, Lars M., et al.
Publicado: (2012)

Dynamics of Minimal Residual Disease in Neuroblastoma Patients
por: Uemura, Suguru, et al.
Publicado: (2019)

The Role and Impact of Minimal Residual Disease in NSCLC
por: Frisone, Daniele, et al.
Publicado: (2021)

Minimal Residual Disease Assessment in Multiple Myeloma Patients: Minimal Disease With Maximal Implications
por: Charalampous, Charalampos, et al.
Publicado: (2022)

Editorial for the Special Issue “Current Development of Pediatric Minimally Invasive Surgery” of the Journal Children
por: Bergholz, Robert, et al.
Publicado: (2023)

Significance of Minimal Residual Disease in Pediatric Mixed Phenotype Acute Leukemia: A Multi-Center Cohort Study
por: Oberley, Matthew J., et al.
Publicado: (2020)

Minimal residual disease (MRD) detection in acute lymphoblastic leukaemia based on fusion genes and genomic deletions: towards MRD for all
por: Kuiper, Roland P., et al.
Publicado: (2021)

Strategies for minimal residual disease detection: current perspectives
por: Andreani, Giacomo, et al.
Publicado: (2019)

Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia
por: Kruse, Aaron, et al.
Publicado: (2020)

Minimal residual disease in multiple myeloma: are we there yet?
por: Devarakonda, Srinivas, et al.
Publicado: (2020)

Minimal residual disease in multiple myeloma: current status
por: Ding, Hong, et al.
Publicado: (2021)

Drug resistance and minimal residual disease in multiple myeloma
por: Gozzetti, Alessandro, et al.
Publicado: (2022)

The therapeutic potential of targeting minimal residual disease in melanoma
por: Patel, Riyaben P, et al.
Publicado: (2023)

Liquid biopsies and minimal residual disease in myeloid malignancies
por: Allam, Sabine, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_eli4q1gbpvhglc8vpo2uc97vl0